Molecular Characterization and Clinical Implications of Endometrial Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Molecular profiling predicts prognosis in endometrial cancer, suggesting personalized treatment options.

Molecular classification of endometrial cancer significantly informs patient prognosis and treatment strategies.
Patients with POLE pathogenic mutations demonstrate nearly no recurrence or death events, indicating excellent outcomes.
Assessments for mismatch repair and p53 abnormalities are essential in molecular classification, guiding clinical decisions.
Ongoing updates in guidelines highlight the necessity of routine molecular testing for endometrial cancer patients.

Secord et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark